U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06872242) titled 'Italian PheNotypes Obstructive Sleep Apnea Study' on Feb. 28.
Brief Summary: Obstructive Sleep Apnea (OSA) is the most common sleep-related breathing disorder, representing a major socioeconomic burden on healthcare systems worldwide. Studies performed in Europe in the last twenty years showed a very high prevalence and highlighted that the severity of untreated OSA worsens over time. OSA is associated also with an increased risk to develop cardiovascular, cerebrovascular and metabolic diseases. Finally, recent studies reported a very high mortality in untreated OSA patients, including those with mild severity.
Data on European po...